• About
    • What We Do
    • Management Team
    • Board of Directors
  • Platform
  • Pipeline
    • Overview
    • IBIO-101
    • IBIO-100
    • IBIO-400
  • Media/Events
    • Press Releases
    • In the News
    • Events
  • Careers
  • Investors
  • Contact
Investors

Press Releases

Investors

Investors

  • Overview
  • Company Info
    • Profile
    • Management Team
    • Presentations
  • News & Events
    • Press Releases
    • IR Calendar
  • Stock Data
    • Quote
    • Historical Data
  • SEC Filings
  • Corporate Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • IR Contact
    • Email Alerts
    • Investor FAQ
  • News & Events

  • Press Releases
  • IR Calendar
Aug 26, 2021 7:00am EDT

iBio Appoints William D. Clark to its Board of Directors

Aug 25, 2021 7:30am EDT

iBio Expands Immuno-Oncology Pipeline in AI Partnership with RubrYc Therapeutics

Jul 15, 2021 5:10pm EDT

iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate

Jul 08, 2021 4:15pm EDT

iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs

Jun 09, 2021 4:30pm EDT

iBio Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive, Eef Schimmelpennink

May 19, 2021 4:30pm EDT

iBio to Present at the UBS Global Healthcare Virtual Conference

May 17, 2021 7:00am EDT

iBio Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update

May 10, 2021 8:15am EDT

iBio to Report Fiscal 2021 Third Quarter Financial Results and Provide Corporate Update on Monday, May 17, 2021

May 06, 2021 4:15pm EDT

iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program

May 04, 2021 5:00pm EDT

iBio and Fraunhofer USA Conclude Litigation and Enter License Agreement

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …16
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Home
  • About
  • Pipeline
  • Platform
  • Media/Events
  • Careers
  • Investors
  • Contact

Headquarters

8800 HSC Pkwy
Bryan, TX 77807

Research & Development

11750 Sorrento Valley Road
Suite 200
San Diego, CA 92121

(979) 446-0027
LinkedIn
info@ibioinc.com
RSS News Feed
© 2023 iBio, Inc. All Rights Reserved.
PRIVACY POLICY AND TERMS OF USE.